HIM
ABBV icon

Hotaling Investment Management’s AbbVie ABBV Stock Holding History

Hotaling Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$3.81M Buy
23,601
+75
+0.3% +$11.5K 1.72% 15
2022
Q3 		$3.16M Buy
23,526
+419
+2% +$60.1K 1.51% 18
2022
Q2 		$3.54M Buy
23,107
+1,087
+5% +$166K 1.54% 16
2022
Q1 		$3.57M Buy
22,020
+4,666
+27% +$678K 1.37% 15
2021
Q4 		$2.35M Sell
17,354
-26
-0.1% -$3.07K 0.82% 41
2021
Q3 		$1.88M Buy
17,380
+344
+2% +$39.3K 0.78% 44
2021
Q2 		$1.92M Buy
17,036
+13,067
+329% +$1.47M 0.78% 45
2021
Q1 		$429K Sell
3,969
-100
-2% -$10.7K 0.19% 85
2020
Q4 		$436K Sell
4,069
-25
-0.6% -$2.4K 0.2% 79
2020
Q3 		$359K Sell
4,094
-7,385
-64% -$695K 0.19% 83
2020
Q2 		$1.13M Buy
11,479
+7,310
+175% +$644K 0.65% 55
2020
Q1 		$318K Sell
4,169
-95
-2% -$8.09K 0.24% 79
2019
Q4 		$378K Buy
4,264
+405
+10% +$33.6K 0.22% 81
2019
Q3 		$292K Sell
3,859
-448
-10% -$30.7K 0.19% 87
2019
Q2 		$313K Buy
4,307
+5
+0.1% +$393 0.2% 87
2019
Q1 		$347K Sell
4,302
-329
-7% -$26.9K 0.23% 85
2018
Q4 		$427K Buy
+4,631
New +$407K 0.35% 73

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hotaling Investment Management's ABBV Position: Q4 2022 in Review

Hotaling Investment Management increased its AbbVie (ABBV) stake by 0.32% in Q4 2022, buying an estimated $11.5K and bringing the position to 23,601 shares worth $3.81M. The position accounts for 1.72% of the portfolio, ranked #15.

Hotaling Investment Management first reported a position in ABBV in Q4 2018 and has held it in 17 quarters since. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Hotaling Investment Management held 23,601 shares of AbbVie worth $3.81M as of Q4 2022.
  • Hotaling Investment Management bought 75 AbbVie shares in Q4 2022, an estimated $11.5K.
  • AbbVie made up 1.72% of Hotaling Investment Management's portfolio in Q4 2022, its #15 holding.
  • Hotaling Investment Management first reported a position in AbbVie in Q4 2018 and has held it in 17 quarters since.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Hotaling Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.